Guidance

Hib/MenC risk groups: patient group direction (PGD) template

PGD template to support the provision of Hib/MenC vaccine to individuals with underlying medical conditions.

• From: Public Health England
• Published: 7 November 2016
• Last updated: 11 October 2018 — See all updates

This publication was withdrawn on 1 August 2020

Immunisation against infectious disease: ‘The Green Book’ no longer recommends additional Hib/MenC vaccine for risk groups. From 1 August 2020, please refer to the Hib/MenC PGD for administration of Hib/MenC vaccine in accordance with national recommendations.

Documents

[Withdrawn] Hib/MenC risk groups: patient group direction (PGD) template

Ref: PHE publications gateway number: 2018514

MS Word Document, 132 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the provision of additional Haemophilus influenzae type b and meningococcal C conjugate vaccine doses to individuals with underlying medical conditions from 2 years of age.

It is valid from 1 November 2018 to 31 October 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 7 November 2016

Last updated 11 October 2018 + show all updates

1. 11 October 2018

   Added routine update.

2. 7 November 2016

   First published.